Nazende Günday-Türeli is the Chief Strategy and Innovation Officer at MyBiotech in charge of defining and executing the long-term strategy and vision roadmap, defining and managing the Research & Development /Innovation landscape and establishing R&D/I partnerships.

Nazende studied Chemistry at Bogazici University, Istanbul. She is MSc in Biotechnology and holds a PhD in Biopharmacy and Pharmaceutical Technology from Saarland University, Germany. She has been working in industry since 20 years focusing on translational research leading several multi- and interdisciplinary teams in international contract research, development and manufacturing organisations. She is a recognized coordinator and principle investigator of international, multidisciplinary collaboration projects with experts and stakeholders across the pharmaceuticals field, including PHOENIX Open Innovation Test Bed for GMP Manufacturing of Nanopharmaceuticals. She is also the CEO of the newly established PHOENIX OITB gGmbH offering a consilated expertise network for fostering nanopharmaceuticals innovation towards clinics by offering a Single Entry Point to a large portfolio of services, from discovery till GMP manufacturing.